PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
202.31%
Revenue growth above 1.5x 4997.T's 76.89%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
157.37%
Gross profit growth 1.25-1.5x 4997.T's 113.70%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
9397.65%
EBIT growth above 1.5x 4997.T's 1127.84%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
6731.65%
Operating income growth above 1.5x 4997.T's 1127.84%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
2551.92%
Net income growth above 1.5x 4997.T's 610.33%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
2619.15%
EPS growth above 1.5x 4997.T's 610.47%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
2619.15%
Diluted EPS growth above 1.5x 4997.T's 610.47%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-76.37%
Negative 10Y revenue/share CAGR while 4997.T stands at 48.64%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
232.45%
5Y revenue/share CAGR above 1.5x 4997.T's 26.88%. David Dodd would look for consistent product or market expansions fueling outperformance.
157.40%
Positive 3Y CAGR while 4997.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-100.00%
Negative 10Y OCF/share CAGR while 4997.T stands at 100.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
111.29%
Net income/share CAGR above 1.5x 4997.T's 55.09% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
548.37%
5Y net income/share CAGR above 1.5x 4997.T's 39.51%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
159.94%
Positive short-term CAGR while 4997.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
-55.85%
Negative equity/share CAGR over 10 years while 4997.T stands at 60.48%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
60.52%
5Y equity/share CAGR 1.25-1.5x 4997.T's 42.19%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
36.36%
3Y equity/share CAGR above 1.5x 4997.T's 10.32%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.79%
AR growth well above 4997.T's 51.75%. Michael Burry fears inflated revenue or higher default risk in the near future.
-46.20%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-18.86%
Negative asset growth while 4997.T invests at 5.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
11.64%
BV/share growth above 1.5x 4997.T's 4.38%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-36.17%
We’re deleveraging while 4997.T stands at 17.72%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
298.15%
R&D growth of 298.15% while 4997.T is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
15.55%
SG&A growth of 15.55% while 4997.T is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.